Work Area: Patents

Unpicking the implications of Oppo v Nokia and what it means for global licence rates

Featured in SEP/FRAND Hub 2023/2024

The First Intermediate People’s Court of Chongqing Municipality has handed down the world’s first aggregate royalty rate for 5G, evaluated the strength of Nokia’s patent portfolio and determined a value contribution ratio for 5G, 4G, 3G and 2G technologies, confirming Oppo’s obligation to pay for the use of Nokia’s patents.

23 January 2024

FTC challenges over 100 patents in FDA’s Orange Book

The Federal Trade Commission has disputed over 100 patents in the Food and Drug Administration’s Orange Book that the agency says may stall generic competition.

08 November 2023

General Court rejects Teva’s bid to overturn €60.5 million pay-for-delay fine

Drugmaker Teva and its subsidiary Cephalon have failed to quash a European Commission decision imposing €60.5 million in fines on the companies for entering into an illegal pay-for-delay agreement for a sleep disorder drug.

18 October 2023

Sanofi denies abuse of FDA’s Orange Book

Sanofi-Aventis says that Mylan Pharmaceuticals’ allegations that it illegally cornered the market for long-lasting insulin are merely a mishmash of “antitrust buzz words”.

19 September 2023

Chipmaker rejects “bounty” allegations

Semiconductor manufacturer MediaTek says a rival’s allegations that it hired a patent troll to corner off a market for television chips is a fanciful tale already rejected by the International Trade Commission and a federal judge in Texas.

06 September 2023

Legislative reforms to overhaul ‘unfavourable’ patent landscape – for better or worse

Featured in SEP/FRAND Hub 2022/2023

Both the PREVAIL Act and Patent Eligibility Restoration Act seek to enhance participation in the patent system. However, expanded eligibility and a weaker PTAB will undoubtably raise concerns from both SEP holders and implementers, and it remains to be seen whether these approaches will ultimately benefit or harm the larger market.

24 August 2023

Legislative reforms to overhaul ‘unfavourable’ patent landscape – for better or worse

Featured in SEP/FRAND Hub 2023/2024

Both the PREVAIL Act and Patent Eligibility Restoration Act seek to enhance participation in the patent system. However, expanded eligibility and a weaker PTAB will undoubtedly raise concerns from both SEP holders and implementers, and it remains to be seen whether these approaches will ultimately benefit or harm the larger market.

24 August 2023

Italy fines cabling system company for sham litigation

Cable and pipe sealing manufacturer Roxtec must pay a €15 million fine for abusing its dominant position by using patent litigation to discredit the reputation of its closest rival, Italy's Competition Authority has said.

17 August 2023

Biotech company did not file "baseless" bovine genetic patent suits, judge says

Biotechnology manufacturer STGenetics did not violate US antitrust laws when it accused a bovine genetic services provider of infringing nine of its patents to process sexed semen straws because its claims were not “objectively baseless," a federal judge in Wisconsin has ruled.

15 August 2023

Availability of preliminary injunctions makes Brazil an attractive litigation venue for SEP owners

Featured in SEP/FRAND Hub 2023/2024

Brazil has become a prominent venue for SEP litigation, mainly due to the early remedies that courts provide, particularly in Rio de Janeiro. As a result, there is an increasing number of declaratory judgment suits being filed by implementers aiming to secure other venues. However, this tactic is not deterring patent assertion.

09 August 2023

Unlock unlimited access to all Global Competition Review content